TIME INTERVAL BETWEEN REPEATED INJECTIONS CONDITIONS THE DURATION OF MOTOR IMPROVEMENT TO APOMORPHINE IN PARKINSONS-DISEASE

被引:34
作者
GRANDAS, F
GANCHER, S
LERA, G
RODRIGUEZ, M
WOODWARD, WR
NUTT, J
OBESO, JA
机构
[1] UNIV NAVARRA CLIN,DEPT NEUROL,MOVEMENT DISORDERS UNIT,APDO 192,E-31080 PAMPLONA,SPAIN
[2] OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201
关键词
D O I
10.1212/WNL.42.7.1287
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Behavioral hyposensitivity to repeated apomorphine administration occurs in fluctuating parkinsonian patients. To determine to what extent the interval between doses influences the response, we administered equal paired apomorphine injections to 10 fluctuating parkinsonian patients. Subjects received two apomorphine injections at 2-hour and at 4-hour intervals on different days after a 10- to 12-hour overnight period without levodopa. Following apomorphine doses at 2-hour intervals, the duration of response was reduced by 40% (61 versus 42 minutes, p < 0.001) but was of equal duration when the doses were given at 4-hour intervals. These findings indicate that the interval between doses is a critical determinant of motor response. We postulate a time-dependent period of partial hyposensitivity to pulsatile DA stimulation.
引用
收藏
页码:1287 / 1290
页数:4
相关论文
共 16 条
  • [1] [Anonymous], 1982, MOVEMENT DISORD
  • [2] INCREASED OR DECREASED LOCOMOTOR RESPONSE IN RATS FOLLOWING REPEATED ADMINISTRATION OF APOMORPHINE DEPENDS ON DOSAGE INTERVAL
    CASTRO, R
    ABREU, P
    CALZADILLA, CH
    RODRIGUEZ, M
    [J]. PSYCHOPHARMACOLOGY, 1985, 85 (03) : 333 - 339
  • [3] ACUTE EFFECTS OF PULSATILE LEVODOPA ADMINISTRATION ON CENTRAL DOPAMINE PHARMACODYNAMICS
    DAVIS, TL
    BRUGHITTA, G
    BARONTI, F
    MOURADIAN, MM
    [J]. NEUROLOGY, 1991, 41 (05) : 630 - 633
  • [4] LEVODOPA PHARMACOKINETIC MECHANISMS AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE
    FABBRINI, G
    JUNCOS, J
    MOURADIAN, MM
    SERRATI, C
    CHASE, TN
    [J]. ANNALS OF NEUROLOGY, 1987, 21 (04) : 370 - 376
  • [5] SUBCUTANEOUS APOMORPHINE IN THE TREATMENT OF PARKINSONS-DISEASE
    FRANKEL, JP
    LEES, AJ
    KEMPSTER, PA
    STERN, GM
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (02) : 96 - 101
  • [6] GANCHER S T, 1991, Neurology, V41, P211
  • [7] PERIPHERAL PHARMACOKINETICS OF APOMORPHINE IN HUMANS
    GANCHER, ST
    WOODWARD, WR
    BOUCHER, B
    NUTT, JG
    [J]. ANNALS OF NEUROLOGY, 1989, 26 (02) : 232 - 238
  • [8] PERIPHERAL PHARMACOKINETICS OF LEVODOPA IN UNTREATED, STABLE, AND FLUCTUATING PARKINSONIAN-PATIENTS
    GANCHER, ST
    NUTT, JG
    WOODWARD, WR
    [J]. NEUROLOGY, 1987, 37 (06) : 940 - 944
  • [9] DIURNAL RESPONSIVENESS TO APOMORPHINE
    GANCHER, ST
    NUTT, JG
    [J]. NEUROLOGY, 1987, 37 (07) : 1250 - 1253
  • [10] MOTOR RESPONSE FOLLOWING REPEATED APOMORPHINE ADMINISTRATION IS REDUCED IN PARKINSONS-DISEASE
    GRANDAS, F
    OBESO, JA
    [J]. CLINICAL NEUROPHARMACOLOGY, 1989, 12 (01) : 14 - 22